Dietary Modification: Clinical Trials

5 trials of Dietary Modification, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 recruiting. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Terminated 2, Recruiting 1

Follow Dietary Modification: new trials by email Literature Review of Dietary Modification trials Research Report on Dietary Modification

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
Balstilimab, Biospecimen Collection, Botensilimab - Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 1RecruitingUniversity of Southern California152025-01-152026-03-17
Dietary Intervention in Patients with a History of Melanoma
Dietary Intervention, Questionnaire Administration - Melanoma
Phase 1TerminatedM.D. Anderson Cancer Center132019-04-162024-12-04
Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer
Dietary Intervention, Laboratory Biomarker Analysis, Paclitaxel - Stage IV Breast Cancer AJCC v6 and v7
Phase 1CompletedOhio State University Comprehensive Cancer Center202017-10-202025-06-08
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer
abiraterone acetate, dietary intervention, pharmacological study - Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer
Phase 1TerminatedOHSU Knight Cancer Institute32013-07-012017-04-28
Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery
lyophilized black raspberry confection, laboratory biomarker analysis, dietary intervention - Stage I Prostate Cancer, Stage IIA Prostate Cancer
Phase 1CompletedOhio State University Comprehensive Cancer Center602012-10-172026-05-20

Conditions studied

Prostatic Neoplasms (2)  ·  Colorectal Neoplasms (1)  ·  Melanoma (1)

Sponsors

Ohio State University Comprehensive Cancer Center (2)  ·  M.D. Anderson Cancer Center (1)  ·  OHSU Knight Cancer Institute (1)  ·  University of Southern California (1)

Countries

United States (5)

Top investigators

Diana Hanna, MD (1)  ·  Jeff Volek, PhD (1)  ·  Jennifer McQuade (1)  ·  Steven Clinton (1)  ·  Tomasz Beer (1)

Results publications

PMID 27813248, PMID 32112501, PMID 38166036

NIH funding

P30CA014089 (1), P30CA069533 (1)